Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Synvista Therapeutics, a biopharmaceutical company, has appointed William Federici to its board of directors, expanding the board to five members.
Subscribe to our email newsletter
Mr Federici joined West Pharmaceutical Services as vice president and CFO in August 2003. He has more than 20 years of public accounting experience, and was previously national industry director for pharmaceuticals of KPMG from June 2002 until August 2003.
Noah Berkowitz, president and CEO of Synvista, said: We are fortunate that Bill has agreed to join our board, and we intend to tap into his significant knowledge base with respect to both his financial and pharmaceutical experience.
We believe his background is a perfect fit for Synvista as we grow from a development stage company to one on the verge of launching a diagnostic product into the $79 billion diabetes market.